Healthcare Realty Trust (HR) Q4 2024 earnings summary

Executive summary

• Leadership changes included a new interim CEO, new independent directors, and a new CFO, bringing renewed focus and energy to management.

• Strategic priorities for 2025 emphasize operational growth, portfolio refinement, and significant debt reduction.

• The CEO search is ongoing, with a focus on finding the right long-term leader.

• Reported net loss attributable to common stockholders of $(106.8) million, or $(0.31) per diluted share for Q4 2024.

• Announced a quarterly dividend of $0.31 per share, payable March 19, 2025.

Financial highlights

• Normalized FFO per share for Q4 2024 was $0.40, up 2.5% year-over-year and at the high end of guidance; full-year Normalized FFO per share reached $1.56.

• Q4 2024 rental income was $300.1 million; full-year rental income was $1.23 billion.

• Same-store Cash NOI grew 3.1% in Q4 and 2.9% for the year; excluding bankrupt tenants, growth was 3.6% and 3.1%, respectively.

• $1.3 billion in capital was raised, including $500 million from non-core asset sales.

• $510 million was allocated to repurchase 31 million shares, and $350 million of debt was repaid, ending the year at 6.4x leverage.

Outlook and guidance

• 2025 guidance targets same-store absorption of 75-125 basis points and same-store NOI growth of 3%-3.75%.

• 2025 normalized FFO per share guidance range: $1.48 to $1.60.

• $400-$500 million in non-core asset sales planned for 2025, with proceeds prioritized for leasing capital and debt repayment.

• Leverage targeted to decline to 6.0-6.25x by year-end 2025.

• Dividend coverage expected by Q4 2025 or early 2026, depending on leasing activity.